Symbol
| NFE2L1
| contributors: mct/shn - updated : 07-03-2015
|
HGNC name
| nuclear factor (erythroid-derived 2)-like 1
|
HGNC id
| 7781
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
NFE2L1 deficiency leads to the reduced expression of the transcriptional coactivator genes LPIN1 and PPARGC1B  | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| |
|
System | Type | Disorder | Pubmed |
cancer | | |  |
NFE2L1-mediated proteasome homeostasis could be an attractive target for therapeutic intervention in cancer |
| | |
| disruption of the transcription factor Nrf-1 results in anemia and embryonic lethality in mice  | |
mice with somatic inactivation of nrf1 in the liver develop hepatic cancer whose livers exhibit steatosis, apoptosis, necrosis, inflammation, and fibrosis  |